PERIPHERAL T CELL LYMPHOMA
Clinical trials for PERIPHERAL T CELL LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new PERIPHERAL T CELL LYMPHOMA trials appear
Sign up with your email to follow new studies for PERIPHERAL T CELL LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo trial aims to boost fight against aggressive lymphoma
Disease control TerminatedThis study is testing whether adding the drug tazemetostat to standard CHOP chemotherapy works better for people with newly diagnosed T cell lymphoma. About 24 participants will receive the combination treatment, and researchers will measure how well the cancer responds and how l…
Matched conditions: PERIPHERAL T CELL LYMPHOMA
Phase: PHASE2 • Sponsor: Eric Jacobsen, MD • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC
-
Pfizer tests new cancer drug combo in early human trial
Disease control OngoingThis early-stage study is testing the safety of a new cancer drug called PF-08046032, both by itself and combined with another drug called sasanlimab. It involves a small group of adults with advanced or spreading cancers, including certain lymphomas and solid tumors like lung ca…
Matched conditions: PERIPHERAL T CELL LYMPHOMA
Phase: PHASE1 • Sponsor: Pfizer • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
Cancer center seeks best treatment for aggressive lymphoma
Disease control ENROLLING_BY_INVITATIONThis study aims to find the most effective and safest first treatment for peripheral T-cell lymphoma, a type of blood cancer. Researchers will compare four different chemotherapy and immunotherapy combinations used at a single cancer center. The study will look at how well each t…
Matched conditions: PERIPHERAL T CELL LYMPHOMA
Phase: PHASE3 • Sponsor: N.N. Petrov National Medical Research Center of Oncology • Aim: Disease control
Last updated Mar 23, 2026 15:19 UTC
-
Could a simple blood test track a rare cancer?
Knowledge-focused OngoingThis study is testing whether a new type of blood test can be used to monitor a rare and aggressive form of blood cancer called peripheral T-cell lymphoma. Researchers will analyze DNA from tumors that circulates in the blood of 45 patients who are newly diagnosed or whose cancer…
Matched conditions: PERIPHERAL T CELL LYMPHOMA
Sponsor: Centre Henri Becquerel • Aim: Knowledge-focused
Last updated Apr 01, 2026 14:42 UTC